
First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence and Pharmacodynamics
December 2016
Click for full info +First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence and Pharmacodynamics
![]() | 15 December 2016 |
In this Journal Article:
Health Risk(s):HIV
Product Type(s):Microbicides MPTs
Topic(s):MPTs Product Development Product Trials
Full Info:
Resource Type:
Citation:
A First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Friedland, B,A., Hoesley, C.J., Plagianos, M., Hoskin, E., Zhang, S., Teleshova, N., …Creasy, G. (2016, July). Journal of Acquired Immune Deficiency Syndromes.
Authors:
A First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Friedland, B,A., Hoesley, C.J., Plagianos, M., Hoskin, E., Zhang, S., Teleshova, N., …Creasy, G.
Health Risks(s):
- HIV
Product type(s):
- Microbicide
- MPTs
Topic(s):
- MPTs
- Development
- Trials
URL of resource: